RHÖN-KLINIKUM AG | 10/27/2011

RHÖN-KLINIKUM AG continues its growth course in line with forecasts

  • Patient numbers climb by 10.9% to over 1.7 million
  • Further growth on nine-month comparison: revenues € 1.96 billion (+ 2.9%) / net consolidated profit € 120.3 million (+ 12.2%)
  • Operating EBITDA € 243.8 million (+ 6.7%) / EBIT € 153.0 million (+ 3.4%)
  • Forecast for full-year 2011 reaffirmed

RHÖN-KLINIKUM AG confirms a successful course of the first nine months of 2011, continuing its growth course in line with forecasts:

A total of 1,701,489 patients were treated in the Group’s hospitals in the first nine months of the current financial year. That translates into a rise of 10.9% compared with the same period last year. Revenues climbed by 2.9% to roughly € 1.96 billion. During the reporting period, net consolidated profit stood at € 120.3 million, exceeding the figure of the same period in 2010 by 12.2%. During the same period, operating EBITDA grew by 6.7% to € 243.8 million. The reported EBITDA was boosted by a one-off, non-operative extraordinary effect. EBIT grew in the first three quarters of 2011 by 3.4% to reach € 153 million. 

“We see ourselves as the mover and initiator for structures that are viable for the future thanks to our highly integrated care structures – also reaching beyond the bounds of our hospitals or practices – and our unique healthcare network within the Group. By steadily expanding medical care networks, we are creating the basis for the good medical care of tomorrow available to everyone”, said Wolfgang Pföhler, chairman of the Board of Management of RHÖN-KLINIKUM AG. 

After deducting minority interests in profit of € 3.5 million from net consolidated profit of the first nine months, earnings per share (EPS) stands at € 0.85 (previous year: € 0.75).


Based on the trend in service volumes and earnings for the first nine months, the chairman of the Board of Management continues to expect financial year 2011 as a whole – excluding further acquisitions and under the currently known statutory framework conditions – to post revenues of roughly € 2.65 billion, an operating EBITDA of € 340 million and a net consolidated profit of € 160 million, with the last two figures potentially fluctuating within a range of plus or minus 5%.

“Achieving consistent efficiency gains to further raise consolidated earnings”

With regard to financial year 2011, Pföhler emphasised: “In the further course of the year we will steadfastly seek efficiency gains from optimisation programmes at our individual hospital sites. We moreover expect to see improvements in service volumes and revenues that will steadily lead to an increase in our consolidated earnings”, Pföhler concluded.